SERPINB7 Expression Predicts Poor Pancreatic Cancer Survival Upon Gemcitabine Treatment.

Bianconi, Daniela; Herac, Merima; Spies, Daniel; Kieler, Markus; Brettner, Robert; Unseld, Matthias; Fürnkranz, Katrin; Famler, Barbara; Schmeidl, Margit; Minichsdorfer, Christoph; Zielinski, Christoph; Heller, Gerwin; Prager, Gerald W

Bianconi, Daniela; Herac, Merima; Spies, Daniel; Kieler, Markus; Brettner, Robert; Unseld, Matthias; Fürnkranz, Katrin; Famler, Barbara; Schmeidl, Margit; Minichsdorfer, Christoph; Zielinski, Christoph; Heller, Gerwin; Prager, Gerald W.

Afiliação

Bianconi D; Department of Internal Medicine I, Comprehensive Cancer Center Vienna, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria.
Herac M; Clinical Institute of Pathology, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria.
Spies D; Swiss Federal Institute of Technology Zurich, Department of Biology, Institute of Molecular Health Sciences, Otto-Stern Weg 7, 8093 Zurich, Switzerland; Life Science Zurich Graduate School, Molecular Life Science Program, University of Zurich, Institute of Molecular Life Sciences, Winterthurerstrass
Kieler M; Department of Internal Medicine I, Comprehensive Cancer Center Vienna, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria.
Brettner R; Department of Internal Medicine I, Comprehensive Cancer Center Vienna, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria.
Unseld M; Department of Internal Medicine I, Comprehensive Cancer Center Vienna, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria.
Fürnkranz K; Department of Internal Medicine I, Comprehensive Cancer Center Vienna, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria.
Famler B; Clinical Institute of Pathology, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria.
Schmeidl M; Clinical Institute of Pathology, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria.
Minichsdorfer C; Department of Internal Medicine I, Comprehensive Cancer Center Vienna, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria.
Zielinski C; Department of Internal Medicine I, Comprehensive Cancer Center Vienna, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria.
Heller G; Department of Internal Medicine I, Comprehensive Cancer Center Vienna, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria.
Prager GW; Department of Internal Medicine I, Comprehensive Cancer Center Vienna, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria. Electronic address: gerald.prager@meduniwien.ac.at.

Transl Oncol ; 12(1): 15-23, 2019 Jan.

Article em En | MEDLINE | ID: mdl-30245304

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Transl Oncol Ano de publicação: 2019 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google